| Bangladesh | India | Nepal |
---|---|---|---|
No. of camps held | 27 | 19 | 2 |
Mean no. of camp attendees$ (range) | 12.9 (01 – 50) | 11.8 (02 – 30) | 29.5 (24 – 35) |
% (No.) male | 48% (168/349) | 52.9% (119/225) | 56% (33/59) |
Mean (SD) age in years | 27.4 (19.1) | 33.1 (18.5) | 33.8 (20.3) |
Detection of VL | Â | Â | Â |
- with splenomegaly | 52% (183/349) | 85.8% (193/225) | 5% (3/59) |
- rK39 test done | 100% (183/183) | 100% (193/193) | 100% (3/3) |
- rK39 positive | 22% (40/183) | 2.6% (5/193) | 100% (3/3) |
- referred for treatment | 100% (40/40) | 100% (5/5) | 100% (3/3) |
- completed treatment | 33% (13/40) | 100% (5/5) | 100% (3/3) |
- No. of new VL cases detected | 40 | 5 | 3 |
- No. of new VL cases detected per camp | 1.5 | 0.3 | 1.5 |
Detection of PKDL | Â | Â | Â |
- with suspected skin lesions | 5% (17/349) | 2.2% (5/225) | 0% (0/59) |
- rK39 test done | 100% (17/17) | 100% (5/5) | -- |
- rK39 test positive | 82% (14/17) | 20% (1/5) | -- |
- referred for treatment | 100% (14/14) | 100% (1/1) | -- |
- completed treatment | 0% (0/14) | 100% (1/1) | -- |
- No. of new PKDL cases detected | 14 | 1 | 0 |
- No. of new PKDL cases detected per camp | 0.5 | .05 | 0 |
No. of new cases (VL + PKDL) detected | 54 | 6 | 3 |
No. of new cases detected per camp | 2.0 | 0.32 | 1.5 |